Source of Support: None, Conflict of Interest: None
Pefloxacin was administered to 35 patients with community acquired lower respiratory tract infections. Eight-six percent of patients responded well to therapy and there was cure of the condition and bacteriological clearance of pathogens including Klebsiella and Streptococcus pneumoniae. There was no superinfection or any adverse effect. There was excellent patient tolerance. The Treatment outcome was significantly better than that of cotrimoxazole.